If you've ever pulled a late night at the college library or at your office, you may have reached for an energy drink or two ...

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Autolus Therapeutics' autologous CD19-directed CAR T-cell therapy Aucatzyl ...

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Don't dismiss persistent fatigue and bruising. These 11 warning signs could indicate acute myelogenous leukemia hiding in ...

Learn about acute myelogenous leukemia (AML), its sneaky symptoms, aggressive nature, and how bone marrow produces defective ...

A new study from the Garvan Institute of Medical Research has found that certain gene variants linked to leukemia may also ...

Two years ago, we introduced you to Tobias and his mother, Charity DeLeon—a brave family thrust into a battle they never anticipated.

Located at the system's hospital in St. George, Utah, the clinic intends to offer T-cell collection closer to home.

The autologous immunotherapy consists of the patient’s own T cells engineered to express a chimeric antigen receptor that ...

An international study has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help doctors better match patients with the therapies ...